SAVA Q3 2017 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1,619

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-0.40

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$687,000

Balance Sheet

Total Assets

$12M

Total Liabilities

$1M

Stockholders' Equity

$11M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,619	-$2,657	+39.1%
Operating Income	-$3M	-$4M	+26.7%
Net Income	-$3M	-$4M	+26.4%